Illegitimate and Repeated Genomic Integration of Cell-Free Chromatin in the Aetiology of Somatic Mosaicism, Ageing, Chronic Diseases and Cancer

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2019 May 31

PMID 31142004

Citations 11

Authors

Gorantla V Raghuram

Shahid Chaudhary

Shweta Johari

Indraneel Mittra

Affiliations

Soon will be listed here.

Abstract

Emerging evidence suggests that an individual is a complex mosaic of genetically divergent cells. Post-zygotic genomes of the same individual can differ from one another in the form of single nucleotide variations, copy number variations, insertions, deletions, inversions, translocations, other structural and chromosomal variations and footprints of transposable elements. High-throughput sequencing has led to increasing detection of mosaicism in healthy individuals which is related to ageing, neuro-degenerative disorders, diabetes mellitus, cardiovascular diseases and cancer. These age-related disorders are also known to be associated with significant increase in DNA damage and inflammation. Herein, we discuss a newly described phenomenon wherein the genome is under constant assault by illegitimate integration of cell-free chromatin (cfCh) particles that are released from the billions of cells that die in the body every day. We propose that such repeated genomic integration of cfCh followed by dsDNA breaks and repair by non-homologous-end-joining as well as physical damage to chromosomes occurring throughout life may lead to somatic/chromosomal mosaicism which would increase with age. We also discuss the recent finding that genomic integration of cfCh and the accompanying DNA damage is associated with marked activation of inflammatory cytokines. Thus, the triple pathologies of somatic mosaicism, DNA/chromosomal damage and inflammation brought about by a common mechanism of genomic integration of cfCh may help to provide an unifying model for the understanding of aetiologies of the inter-related conditions of ageing, degenerative disorders and cancer.

Citing Articles

Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin.

Khanvilkar S, Mittra I Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861193 PMC: 11769567. DOI: 10.3390/ph18010132.

Stratification of Gut Microbiota Profiling Based on Autism Neuropsychological Assessments.

Marangelo C, Vernocchi P, Del Chierico F, Scanu M, Marsiglia R, Petrolo E Microorganisms. 2024; 12(10).

PMID: 39458350 PMC: 11510388. DOI: 10.3390/microorganisms12102041.

Exploiting the damaging effects of ROS for therapeutic use by deactivating cell-free chromatin: the alchemy of resveratrol and copper.

Mittra I Front Pharmacol. 2024; 15:1345786.

PMID: 38455966 PMC: 10917901. DOI: 10.3389/fphar.2024.1345786.

A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice.

Pal K, Raghuram G, DSouza J, Shinde S, Jadhav V, Shaikh A Sci Rep. 2022; 12(1):17209.

PMID: 36241685 PMC: 9568542. DOI: 10.1038/s41598-022-21388-w.

A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001).

Agarwal A, Khandelwal A, Pal K, Khare N, Jadhav V, Gurjar M PLoS One. 2022; 17(2):e0262212.

PMID: 35120140 PMC: 8815866. DOI: 10.1371/journal.pone.0262212.

References

Martincorena I, Fowler J, Wabik A, Lawson A, Abascal F, Hall M . Somatic mutant clones colonize the human esophagus with age. Science. 2018; 362(6417):911-917. PMC: 6298579. DOI: 10.1126/science.aau3879. View

Forsberg L . Loss of chromosome Y (LOY) in blood cells is associated with increased risk for disease and mortality in aging men. Hum Genet. 2017; 136(5):657-663. PMC: 5418310. DOI: 10.1007/s00439-017-1799-2. View

Mittra I, Samant U, Sharma S, Raghuram G, Saha T, Tidke P . Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death Discov. 2017; 3:17015. PMC: 5447133. DOI: 10.1038/cddiscovery.2017.15. View

Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J . DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004; 554(1-2):297-304. DOI: 10.1016/j.mrfmmm.2004.05.011. View

Waris G, Ahsan H . Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006; 5:14. PMC: 1479806. DOI: 10.1186/1477-3163-5-14. View

Wan F, Lenardo M . Specification of DNA binding activity of NF-kappaB proteins. Cold Spring Harb Perspect Biol. 2010; 1(4):a000067. PMC: 2773628. DOI: 10.1101/cshperspect.a000067. View

Rekha M, Pal K, Bala P, Shetty M, Mittra I, Bhuvaneshwar G . Pullulan-histone antibody nanoconjugates for the removal of chromatin fragments from systemic circulation. Biomaterials. 2013; 34(27):6328-38. DOI: 10.1016/j.biomaterials.2013.05.019. View

Laurie C, Laurie C, Rice K, Doheny K, Zelnick L, McHugh C . Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet. 2012; 44(6):642-50. PMC: 3366033. DOI: 10.1038/ng.2271. View

Cai X, Evrony G, Lehmann H, Elhosary P, Mehta B, Poduri A . Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep. 2014; 8(5):1280-9. PMC: 4272008. DOI: 10.1016/j.celrep.2014.07.043. View

10.

Ye C, Liu G, Bremer S, Heng H . The dynamics of cancer chromosomes and genomes. Cytogenet Genome Res. 2007; 118(2-4):237-46. DOI: 10.1159/000108306. View

11.

Basak R, Nair N, Mittra I . Evidence for cell-free nucleic acids as continuously arising endogenous DNA mutagens. Mutat Res. 2016; 793-794:15-21. DOI: 10.1016/j.mrfmmm.2016.10.002. View

12.

Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87. PMC: 4290021. DOI: 10.1056/NEJMoa1409405. View

13.

Conlin L, Thiel B, Bonnemann C, Medne L, Ernst L, Zackai E . Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Mol Genet. 2010; 19(7):1263-75. PMC: 3146011. DOI: 10.1093/hmg/ddq003. View

14.

Zhang L, Vijg J . Somatic Mutagenesis in Mammals and Its Implications for Human Disease and Aging. Annu Rev Genet. 2018; 52:397-419. PMC: 6414224. DOI: 10.1146/annurev-genet-120417-031501. View

15.

Du Clos T, Volzer M, Hahn F, Xiao R, Mold C, Searles R . Chromatin clearance in C57Bl/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells. Clin Exp Immunol. 1999; 117(2):403-11. PMC: 1905342. DOI: 10.1046/j.1365-2249.1999.00976.x. View

16.

Mittra I, Khare N, Raghuram G, Chaubal R, Khambatti F, Gupta D . Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci. 2015; 40(1):91-111. PMC: 5779614. DOI: 10.1007/s12038-015-9508-6. View

17.

Hadian K, Krappmann D . Signals from the nucleus: activation of NF-kappaB by cytosolic ATM in the DNA damage response. Sci Signal. 2011; 4(156):pe2. DOI: 10.1126/scisignal.2001712. View

18.

Jacobs K, Mertzanidou A, Geens M, Nguyen H, Staessen C, Spits C . Low-grade chromosomal mosaicism in human somatic and embryonic stem cell populations. Nat Commun. 2014; 5:4227. DOI: 10.1038/ncomms5227. View

19.

Jylhava J, Kotipelto T, Raitala A, Jylha M, Hervonen A, Hurme M . Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: the Vitality 90+ study. Mech Ageing Dev. 2010; 132(1-2):20-6. DOI: 10.1016/j.mad.2010.11.001. View

20.

Kirolikar S, Prasannan P, Raghuram G, Pancholi N, Saha T, Tidke P . Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells. Cell Death Dis. 2018; 9(12):1142. PMC: 6238009. DOI: 10.1038/s41419-018-1181-x. View